Welcome to the Fourth 2018 Issue of The CLL Society Tribune
At this time of year, one cannot miss the bright lights of Hanukkah candles and Christmas decor. They are beacons of unity, thanksgiving, and hope…just the things the CLL Society embodies. We bring patients, caregivers, and blood cancer specialists together through our website, educational forums, patient support groups, interviews with specialists around the world, and more—including this quarterly newsletter.
We are thankful for the patients and caregivers who share their experiences, for the doctors who provide us with insights on our disease, and the researchers who share information about the latest in blood cancer research. And, we are so hopeful for a cure. Over this last year, many have benefitted from new therapies and our knowledge of CLL has increased exponentially. We invite you to share in the spirit of thanksgiving and hope through this last issue of the year of The CLL Tribune. Because we’re all in this together. If you or a loved one has been helped by the CLL Society, please consider making a donation.
By Brian Koffman, MD
Please enjoy my 5-minute interview with Dr. Hillmen who is not only a great clinician and researcher, but also a gifted teacher … Watch The Interview
The topic for the 2018 Q4 CLL Society Tribune ASK & Tell Survey is the unmet, and too often unrecognized, needs of caregivers. Both patients and caregivers are invited to address these questions about their personal experience … Read more
By Richard Furman, MD
Dr. Richard Furman of Weill-Cornell Medical College answers readers’ questions submitted to the CLL Society…Read more
By Thomas E Henry III, MBA, RPh, CPh
Thomas E Henry III, MBA, RPh, CPh from Burlington Consulting Associates answers readers’ pharmacy questions submitted to the CLL Society…Read more
Susan J. Leclair from University of Massachusetts Dartmouth answers readers’ lab scientist questions submitted to the CLL Society…Read more
We’d like to thank the supporters of The CLL Tribune:
- Genentech/Biogen Idec
- Sunesis Pharmaceuticals
- TG Therapeutics
The CLL Society does not provide medical advice or endorsements. Unless explicitly stated otherwise, all content in the CLL Tribune is the opinion or information of its author, not the CLL Society. This newsletter is for reference and educational purposes only and is not a substitute for medical advice. We do not guarantee the accuracy of any of the materials. Always contact your own doctor or other professional healthcare provider if you have any questions concerning your or your family’s health. Everyone’s circumstances are different.